Revista de Medicina Desportiva (English) March 2018 - Page 24

that mesotherapy, when associated with other therapeutic techniques, for instance TENS (Transcutaneous Electric Nerve Stimulation), has faster good results in reducing pain than when they are applied in isolation, which is similar to the results dem- onstrated in other papers, where mesotherapy was associated with other therapeutic techniques, such as TENS and laser or dynamic thera- pies. 14.15 On the beginning of this decade, on a meeting where several medi- cal specialties were present, it was reviewed and validated the rational use, indications, advantages and contraindications of mesotherapy with the purpose to create a series of recommendations of the appro- priate use of Intradermal therapy. It was concluded that intradermal administration is effective to fight pain and it should be considered another therapeutic “weapon” that doctors can use. 16 In the case of the persistence of pain implies a new clinical evaluation and therapeutic decision. 3 Currently, in France, mesotherapy is recognized by the French Medical Academy as a legitimate technique to control pain, its costs are reim- bursed by Social security and it is applied in most sports and in medi- cal centers as well. 17 References 1. Baranowski A, Buffington T, Collett B, et al. Classification of Chronic Pain, Second Edition (Revised). Pain. 2011. 2. Treede RD, Rief W, Barke A, A classification of chronic pain for ICD-11. Pain. 2015; 156:1003-7. 3. Mammucari M, Gatti A, Maggiori S, et al. Role of Mesotherapy in Musculoskeletal Pain: Opinions from the Italian Society of Mesothe- rapy. Evidence-Based Complementary and Alternative Medicine. 2012; 2012:1-12. 4. Mason L, Moore RA, Edwards JE, et al. Topi- cal NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskelet Disord. 2004; 19:5-28. 5. Sivagnanam G.Mesotherapy – The french connection. J Pharmacol Pharmacother. 2010; 1:4-8. 6. Mendonça R, Ramires I. Mesoterapia (2016). Lisboa: 1.ª edição, Lidel. 7. Gancedo HE. Cap 1: Generalidades da Meso- terapia. In Tratado deMesoterapia. El Fenix, 2008. 8. Herreros FOC, Moraes AM, Velho PENF. Mesotherapy: a bibliographical review. Anais Brasileiros de Dermatologia, 2011; 86(1):96–101. 9. Binaglia L, Marconi P and Pitzurra M. Absorption of Na ketoprofen administered intradermally. Giornale di Mesoterapia; 1981; 1:85–91. 10. Hsu CC, Kuo HC, Hsu CT, et al. Abdominal mesotherapy injection extended the absorption of follicle-stimulating hormone. Fertility and Sterility, 2011; 95(6):2134–2136. 11. Herreros F, Aparecida M, et al.Mesotherapy: a bibliographical review. An. Bras. Dermatol. 2011; 86(1):96-101. 12. Coz J. Traité de mésothérapie (2009). Paris: 2.º edition, Masson. Mesoterapia teatment algorithm History and clinical evaluation Mesoterapia with AINEs and Myelogenous drugs NPRS 1-4 NPRS 5-7 NPRS 8-10 NPRS reduction of 70% NPRS reduction of > 70% NPRS reduction of < 50% NPRS reduction of > 70% NPRS reduction of < 50% Weekly sessions for 4 weeks Weekly sessions for 4 weeks Weekly sessions until reduction of NPRS by 50% Weekly sessions until reduction of NPRS by 50% Sessions every 3 days until reduction of NPRS by 50% Fortnightly sessions as needed Fortnightly sessions until reduction of NPRS > 70% Fortnightly sessions as needed Weekly sessions until reduction of NPRS > 50% Weekly sessions until reduction of NPRS > 50% Monthly sessions as needed Fortnightly sessions as needed Algorithm adapted for the use of NSAIDs and myorelaxants on mesotherapy for the muscle-skeletal pain 3 22 march 2018 www.revdesportiva.pt 13. Cereser C, Ganzit GP, and Gribaudo C. Injuries affecting the locomotory system during the game of rugby. Reports of 133 cases treated with mesotherapy. Giornale di Mesoterapia. 1985; (5):9-19. 14. Palermo S, Riello R, Cammardella MP et al. TENS+ mesotherapy association in the therapy of cervico-brachialgia: preliminary data. Minerva Anestesiologica. 1991; 57(10):1084- 1085. 15. Solinas G, Solinas AL, Perra P, and Solinas FL. Treatment of mechanical tendinopathies by mesotherapy with orgotein in combination with laser therapy. Riabilitazione, 1987; 20(4):281–288. 16. Mammucari M, Gatti A, Maggiori S,Bartoletti CA, and Sabato AF. Mesothe- rapy, definition, rationale and clinical role: a consensus report from the Italian Society of Mesotherapy. European Review for Medical and Pharmacological Science, 2011; 15(6):682-69. 17. Laurens, D. Suivitraumatologique des perchis- tes de l’INSEP de juillet 1998 a juillet 2000, presented at the 9 th International mesotherapy meeting of the French Society of Mesotherapy, Paris, October 20-22nd, 2000, pp145-162 of the conference manual.